This company has been marked as potentially delisted and may not be actively trading. NASDAQ:HSTO Histogen (HSTO) Stock Price, News & Analysis Add Compare Share Share Stock Analysis Stock Analysis About Histogen Stock (NASDAQ:HSTO) Get Histogen alerts:Sign Up Key Stats Today's Range$0.0003▼$0.001350-Day Range N/A52-Week Range$0.05▼$0.55Volume1,625 shsAverage Volume10,369 shsMarket Capitalization$5.34 thousandP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview Histogen, Inc. is a clinical‐stage biotechnology company headquartered in San Diego, California, that specializes in the development of regenerative medicine products for hair restoration and skin rejuvenation. The company’s proprietary technology harnesses the secreted growth factors, cytokines and extracellular matrix components produced by “embryonic‐like” human cells cultured under low‐oxygen conditions. By concentrating these biologically active molecules into a conditioned medium, Histogen aims to create off‐the‐shelf therapeutics that stimulate tissue repair and regeneration. Histogen’s lead product candidates include HST‐001, a formulation under investigation for accelerating wound healing and improving skin quality, and HST‐002, a topical treatment designed to promote hair follicle health and counteract androgenetic alopecia. Both programs have advanced through initial clinical evaluations, demonstrating favorable safety profiles and signs of biological activity. The company holds a portfolio of patents protecting its cell‐culture processes and methods of use in dermatological and aesthetic indications. Founded in 2007, Histogen operates research and GMP manufacturing facilities in the United States and collaborates with external laboratories and academic partners to expand its pipeline. Led by founder and Chief Executive Officer Christopher J. Bradley, the company continues to pursue late‐stage clinical development and strategic partnerships aimed at commercializing its regenerative therapeutics worldwide.AI Generated. May Contain Errors. Read More Receive HSTO Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Histogen and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. HSTO Stock News HeadlinesHistogen Inc COM NEW (OTC:HSTO) Stock, Short Interest ReportJuly 11, 2026 | benzinga.comHistogen Inc. (HSTO) Stock Price, News, Quote & History - Yahoo FinanceApril 25, 2024 | finance.yahoo.comChina's dominance in rare earth processing sparks new defense rulesOn January 1, 2027, new Pentagon rules tighten sourcing restrictions on critical minerals tied to foreign adversaries. China controls more than 90% of global rare earth processing capacity, while the U.S. imports 100% of its titanium sponge. SAGA Metals has drilled more than 23,000 meters at its Radar project, with all 92 drill holes intersecting mineralization. A maiden mineral resource estimate is expected in Q4 2026, alongside ongoing drilling at the Wolverine heavy rare earth project.September 22 at 1:00 AM | The Tomorrow Investor (Ad)Histogen Inc: Histogen Files for Voluntary Chapter 11 Protection to Facilitate Wind-Down, Maximize Share OfferingApril 22, 2024 | finanznachrichten.deHistogen Files For Voluntary Chapter 11 Bankruptcy ProtectionApril 18, 2024 | markets.businessinsider.comHistogen files for Chapter 11, seeks liquidationApril 18, 2024 | msn.comHistogen Files for Voluntary Chapter 11 Protection to Facilitate Wind-Down, Maximize Share OfferingApril 18, 2024 | globenewswire.comHistogen Stock (OTC:HSTO) Dividends: History, Yield and DatesFebruary 6, 2024 | benzinga.comSee More Headlines HSTO Stock Analysis - Frequently Asked Questions How were Histogen's earnings last quarter? Histogen Inc. (NASDAQ:HSTO) posted its quarterly earnings results on Wednesday, November, 10th. The company reported ($1.80) earnings per share for the quarter, topping analysts' consensus estimates of ($2.20) by $0.40. The firm had revenue of $0.59 million for the quarter. When did Histogen's stock split? Histogen's stock reverse split before market open on Friday, June 3rd 2022.The 1-20 reverse split was announced on Friday, June 3rd 2022. The number of shares owned by shareholders was adjusted after the closing bell on Friday, June 3rd 2022. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split. What other stocks do shareholders of Histogen own? Based on aggregate information from My MarketBeat watchlists, some other companies that Histogen investors own include Tesla (TSLA), Bionano Genomics (BNGO), HubSpot (HUBS), Meta Platforms (META) and TherapeuticsMD (TXMD). Company Calendar Last Earnings11/10/2021Today9/22/2026Fiscal Year End12/31/2026Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorHealthcare Industry Pharmaceuticals Sub-IndustryPharmaceuticals Current SymbolNASDAQ:HSTO CIK1383701 Webwww.histogen.com Phone(858) 526-3100FaxN/AEmployees20Year Founded2007Profitability EPS (Trailing Twelve Months)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual Sales$19 thousand Price / Sales0.28 Cash FlowN/A Price / Cash FlowN/A Book Value$3.13 per share Price / Book0.00Miscellaneous Outstanding Shares4,270,000Free FloatN/AMarket Cap$5.34 thousand OptionableNot Optionable Beta1.19 Social Links (Almost) Everything You Need To Know About The EV MarketLooking to profit from the electric vehicle mega-trend? Click the link to see our list of which EV stocks show the most long-term potential.Get This Free Report This page (NASDAQ:HSTO) was last updated on 9/22/2026 by MarketBeat.com Staff. From Our PartnersA “bloodbath” Is ComingReports suggest some Silicon Valley billionaires are stockpiling gold, guns, and gas masks - or leaving the co...TradeSmith | SponsoredThe AI Infrastructure Rush Is ON — Watch VDTAVertical Data Inc. (OTCQB: VDTA) is targeting the infrastructure layer beneath the AI boom, from GPU hardware ...Trading Wire | SponsoredA councilman backed AI — then 13 bullets hit his front doorThirteen bullets hit an Indianapolis councilman's front door days after he backed a data center rezoning. Acro...Stansberry Research | SponsoredThis free guide explains options the way they should be taughtMost options educators jump straight into Greeks, spreads, and implied volatility - losing beginners before th...Base Camp Trading | SponsoredElon Musk’s One Stock Retirement PlanJeff Brown picked Nvidia in 2016, before it surged 37,000 percent. Now he's tracking a small AI company he say...Brownstone Research | SponsoredThe next convergence is hereIn 2006, a flooded mine at Cigar Lake sent uranium prices from the 50 range to 136 in eight months. This pa...Digest Publishing | SponsoredIran War WARNING: Something Just ChangedA powerful Middle Eastern government is reportedly asking Trump for U.S. military help against Iran backed for...Banyan Hill Publishing | SponsoredCongress Just Opened the FloodgatesThe House passed the Digital Asset Market Clarity Act 294 to 134, creating the most comprehensive financial te...Awesomely | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Histogen Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Histogen With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
